Kiniksa Pharmaceuticals, Ltd. KNSA
$ 21.04
-0.8%
Quarterly report 2024-Q3
added 10-29-2024
Country |
USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Sanjiv Patel |
Employees in the company |
135 |
Shares |
70.1 M |
Market Cap[1] |
$ 1.47 B |
EBITDA (LTM) |
$ -36.3 M |
P/E (LTM) |
-33.72 |
P/S (LTM) |
4.43 |
EPS (LTM) |
-0.69 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.